Lupus Science & Medicine最新文献

筛选
英文 中文
Impact of pregnancy on organ damage in systemic lupus erythematosus: a multicentre study. 妊娠对系统性红斑狼疮器官损害的影响:一项多中心研究。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-22 DOI: 10.1136/lupus-2026-002269
Dina Zucchi, Giancarlo Cascarano, Greta Hulej, Maria Laura Manca, Elena Elefante, Francesca Monacci, Martina Benvenuti, Chiara Ietto, Sabrina Gori, Maddalena Larosa, Margherita Zen, Marta Mosca, Chiara Tani
{"title":"Impact of pregnancy on organ damage in systemic lupus erythematosus: a multicentre study.","authors":"Dina Zucchi, Giancarlo Cascarano, Greta Hulej, Maria Laura Manca, Elena Elefante, Francesca Monacci, Martina Benvenuti, Chiara Ietto, Sabrina Gori, Maddalena Larosa, Margherita Zen, Marta Mosca, Chiara Tani","doi":"10.1136/lupus-2026-002269","DOIUrl":"https://doi.org/10.1136/lupus-2026-002269","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Immune-Inflammation Index (SII) correlates with disease activity but not with interferon-associated chemokines in SLE. 系统性免疫炎症指数(SII)与SLE患者的疾病活动性相关,但与干扰素相关趋化因子无关。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-22 DOI: 10.1136/lupus-2026-002246
Diana Estefania Campos-Andaluz, Regina Sánchez-Montes, Laura Barragán-Huerta, Ricardo Márquez-Velasco, Luis M Amezcua-Guerra
{"title":"Systemic Immune-Inflammation Index (SII) correlates with disease activity but not with interferon-associated chemokines in SLE.","authors":"Diana Estefania Campos-Andaluz, Regina Sánchez-Montes, Laura Barragán-Huerta, Ricardo Márquez-Velasco, Luis M Amezcua-Guerra","doi":"10.1136/lupus-2026-002246","DOIUrl":"https://doi.org/10.1136/lupus-2026-002246","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatigue outcomes with anifrolumab in low-disease-activity SLE: DNA damage in plasmacytoid dendritic cells as a candidate biomarker for responders. 低疾病活动性SLE患者anfrolumab的疲劳结果:浆细胞样树突状细胞DNA损伤作为应答者的候选生物标志物
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-20 DOI: 10.1136/lupus-2026-002234
Eitaro Yoshida, Taiga Kuga, Yusuke Yanagimoto, Emi Nakanishi, Ayako Makiyama, Goh Murayama, Kentaro Minowa, Makio Kusaoi, Ken Yamaji, Naoto Tamura
{"title":"Fatigue outcomes with anifrolumab in low-disease-activity SLE: DNA damage in plasmacytoid dendritic cells as a candidate biomarker for responders.","authors":"Eitaro Yoshida, Taiga Kuga, Yusuke Yanagimoto, Emi Nakanishi, Ayako Makiyama, Goh Murayama, Kentaro Minowa, Makio Kusaoi, Ken Yamaji, Naoto Tamura","doi":"10.1136/lupus-2026-002234","DOIUrl":"10.1136/lupus-2026-002234","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149228115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective evaluation assessing the influence of outcome definition, cohort inclusion and DORIS remission in predicting adverse pregnancy outcomes in women with systemic lupus erythematosus. 前瞻性评价评估结局定义、队列纳入和DORIS缓解对预测系统性红斑狼疮妇女不良妊娠结局的影响。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-16 DOI: 10.1136/lupus-2026-002210
Camila Hernández-Blanco, Philip M Carlucci, Erin Carter, Blake Lippman, Peter Izmirly, Alexis Engel, Jane Salmon, Jessica Dai, Mala Masson, H Michael Belmont, Amit Saxena, Justin S Brandt, Jill P Buyon
{"title":"Prospective evaluation assessing the influence of outcome definition, cohort inclusion and DORIS remission in predicting adverse pregnancy outcomes in women with systemic lupus erythematosus.","authors":"Camila Hernández-Blanco, Philip M Carlucci, Erin Carter, Blake Lippman, Peter Izmirly, Alexis Engel, Jane Salmon, Jessica Dai, Mala Masson, H Michael Belmont, Amit Saxena, Justin S Brandt, Jill P Buyon","doi":"10.1136/lupus-2026-002210","DOIUrl":"10.1136/lupus-2026-002210","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149207420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychometric validation of the Bengali Lupus-QoL and its correlation with disease activity, damage and low disease activity state: a two-centre cross-sectional study. 孟加拉狼疮-生活质量的心理计量学验证及其与疾病活动性、损害和低疾病活动性状态的相关性:一项双中心横断面研究。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-16 DOI: 10.1136/lupus-2026-002213
Ritasman Baisya, Jyotisubhra Das, Vikas Dagar, Sourav Garai, Parasar Ghosh
{"title":"Psychometric validation of the Bengali Lupus-QoL and its correlation with disease activity, damage and low disease activity state: a two-centre cross-sectional study.","authors":"Ritasman Baisya, Jyotisubhra Das, Vikas Dagar, Sourav Garai, Parasar Ghosh","doi":"10.1136/lupus-2026-002213","DOIUrl":"10.1136/lupus-2026-002213","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149207357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PTGS2/COX-2 is associated with neurovascular and blood-brain barrier changes in behaviourally classified MRL/lpr mice. 在行为分类的MRL/lpr小鼠中,PTGS2/COX-2与神经血管和血脑屏障的改变有关。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-12 DOI: 10.1136/lupus-2026-002208
Jianbin Li, Mengxia Liu, Haicheng Wen, Yuxin Yan, Shujiao Yu, Rui Wu
{"title":"PTGS2/COX-2 is associated with neurovascular and blood-brain barrier changes in behaviourally classified MRL/lpr mice.","authors":"Jianbin Li, Mengxia Liu, Haicheng Wen, Yuxin Yan, Shujiao Yu, Rui Wu","doi":"10.1136/lupus-2026-002208","DOIUrl":"10.1136/lupus-2026-002208","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13662092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149167518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suboptimal attainment of SLE treat-to-target goals based on persistently high physician global assessment: an analysis of German SPOCS patients. 基于持续高医师总体评估的系统性红斑狼疮治疗目标的次优实现:对德国SPOCS患者的分析。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-12 DOI: 10.1136/lupus-2026-002168
Martin Aringer, Peter Korsten, Tobias Alexander, Falk Hiepe, Marc Schmalzing, Lioba Pieterse, Mareike Giefer, Julius Brandenburg, Bo Ding, Julia Weinmann-Menke
{"title":"Suboptimal attainment of SLE treat-to-target goals based on persistently high physician global assessment: an analysis of German SPOCS patients.","authors":"Martin Aringer, Peter Korsten, Tobias Alexander, Falk Hiepe, Marc Schmalzing, Lioba Pieterse, Mareike Giefer, Julius Brandenburg, Bo Ding, Julia Weinmann-Menke","doi":"10.1136/lupus-2026-002168","DOIUrl":"10.1136/lupus-2026-002168","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13662087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149169757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
B-cell landscape remodelling following dual BAFF/APRIL inhibition with telitacicept in lupus nephritis: extrafollicular axis clearance and its association with clinical response. 狼疮性肾炎中泰利他塞普双重BAFF/APRIL抑制后的b细胞景观重塑:滤泡外轴清除及其与临床反应的关系
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-08 DOI: 10.1136/lupus-2026-002160
Wenqian Yi, Xiaojun Tang, Hua Wei, Juan Wu, Xiaoman Jiang, Zirui Yang, Jieting Jia, Tao Han, Saisai Huang, Xiaolei Ma, Zi-Yi Jin, Qingfeng Zhang, Yun Zhu, Xuebing Feng, Lingyun Sun
{"title":"B-cell landscape remodelling following dual BAFF/APRIL inhibition with telitacicept in lupus nephritis: extrafollicular axis clearance and its association with clinical response.","authors":"Wenqian Yi, Xiaojun Tang, Hua Wei, Juan Wu, Xiaoman Jiang, Zirui Yang, Jieting Jia, Tao Han, Saisai Huang, Xiaolei Ma, Zi-Yi Jin, Qingfeng Zhang, Yun Zhu, Xuebing Feng, Lingyun Sun","doi":"10.1136/lupus-2026-002160","DOIUrl":"10.1136/lupus-2026-002160","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13656147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149137435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belimumab prevention against organ damage over 8 years and safety up to 13 years: three pooled open-label, long-term extension SLE studies. Belimumab预防器官损害超过8年,安全性长达13年:三项合并开放标签长期扩展SLE研究。
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-05 DOI: 10.1136/lupus-2026-002199
Zahi Touma, Cristina Arriens, Maria G Tektonidou, Ricard Cervera, Roger A Levy, Anne Hammer, Daniel J Wallace
{"title":"Belimumab prevention against organ damage over 8 years and safety up to 13 years: three pooled open-label, long-term extension SLE studies.","authors":"Zahi Touma, Cristina Arriens, Maria G Tektonidou, Ricard Cervera, Roger A Levy, Anne Hammer, Daniel J Wallace","doi":"10.1136/lupus-2026-002199","DOIUrl":"10.1136/lupus-2026-002199","url":null,"abstract":"<p><strong>Objective: </strong>Examine long-term glucocorticoid usage, safety and prevention of organ damage in patients with SLE treated with belimumab plus standard therapy (ST).</p><p><strong>Methods: </strong>This <i>post hoc</i> analysis from three global long-term extension (LTE) studies (BEL112233, BEL112234 and BEL112626) included patients who completed parent studies BLISS-52, BLISS-76 or LBSL02. All patients in the LTEs received open-label belimumab (10 mg/kg) intravenously every 28 days plus ST. Endpoints included long-term SLE medication use any time after first belimumab dose (in parent or LTE study), organ damage accrual (up to 8 years) and safety (up to 13 years).</p><p><strong>Results: </strong>Altogether, 1304 patients enrolled in the LTE studies; 1299 received ≥1 dose of belimumab and were included in the modified intent to treat population. Of these, 1221 (94%) patients were female and at enrolment had a mean (SD) age and disease duration of 39.7 (11.6) and 7.2 (6.7) years, respectively. Mean (SD) baseline Safety of Estrogens in Lupus Erythematosus National Assessment-SLE Disease Activity Index (SELENA-SLEDAI) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) scores were 8.2 (4.3) and 0.7 (1.2), respectively. The most frequently used SLE concomitant medications at any time after first dose of belimumab were glucocorticoid (GC) (94.1%), antimalarials (74.6%) and immunosuppressants (56.4%). Approximately 50% of patients reduced their GC dose to ≤7.5 mg/day in the first 3 years, increasing to 73.6% by the end of year 8. Mean (SD) changes in SDI score to year 8 did not exceed 0.3 (0.6). Overall, 97.5% of patients had ≥1 adverse event (AE) up to 13 years. While 40.4% had ≥1 serious AE, the incidence of AEs leading to belimumab discontinuation generally remained low over time (10.7%).</p><p><strong>Conclusions: </strong>Patients with SLE treated with belimumab reduced GC use and had minimal to no organ damage progression over 8 years. Robust and consistent safety data up to 13 years support the well-established favourable safety profile of belimumab, with no new safety concerns.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13646960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced humoral response to recombinant zoster vaccine in patients with SLE: a prospective cohort study across immune-mediated inflammatory diseases. SLE患者对重组带状疱疹疫苗的体液反应降低:一项免疫介导炎症性疾病的前瞻性队列研究
IF 4.2 2区 医学
Lupus Science & Medicine Pub Date : 2026-10-01 DOI: 10.1136/lupus-2026-002305
Tiphaine Goulenok, Valentine Marie Ferré, Dalil Bouzid, Gaelle Letang, Bernadette Antoine, Jean-Francois Alexandra, Marie-Paule Chauveheid, Julie Chezel, Antoine Dossier, Andrea Pizzuto, Diane Rouzaud, Thomas Papo, Arthur Mageau, Karim Sacre
{"title":"Reduced humoral response to recombinant zoster vaccine in patients with SLE: a prospective cohort study across immune-mediated inflammatory diseases.","authors":"Tiphaine Goulenok, Valentine Marie Ferré, Dalil Bouzid, Gaelle Letang, Bernadette Antoine, Jean-Francois Alexandra, Marie-Paule Chauveheid, Julie Chezel, Antoine Dossier, Andrea Pizzuto, Diane Rouzaud, Thomas Papo, Arthur Mageau, Karim Sacre","doi":"10.1136/lupus-2026-002305","DOIUrl":"https://doi.org/10.1136/lupus-2026-002305","url":null,"abstract":"","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 2","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13630064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书